Concepedia

Complement Therapeutic Dosing

Complement Therapeutic Dosing is a methodological framework within complement-targeted therapy that specifies the precise administration regimen of complement-modulating agents to achieve optimal therapeutic efficacy while minimizing adverse effects.

3

Publications

150

Citations

29

Authors

26

Institutions

Publications per year

2017–2026

2

Parents

Publications

3

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome

Janice L. Zimmerman, R. Phillip Dellinger, Richard Straube et al. · Critical Care Medicine · 2000 · 79 citations

, , +17

Efficacy and safety of the <scp>C5</scp> inhibitor crovalimab in complement inhibitor‐naive patients with <scp>PNH</scp> (<scp>COMMODORE</scp> 3): A multicenter, <scp>Phase</scp> 3, single‐arm study

Hui Liu, Linghui Xia, Jianyu Weng et al. · American Journal of Hematology · 2023 · 38 citations · Full text

, , +15

Management of acute breakthrough hemolysis with intensive pegcetacoplan dosing in patients with PNH

Morag Griffin, Richard J. Kelly, Jens Panse et al. · Blood Advances · 2024 · 33 citations · Full text

, , +12

Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum

David Kavanagh, Gianluigi Ardissino, Vicky Brocklebank et al. · Kidney International · 2024 · 21 citations · Full text

, , +17

1–4 of 3

Authors

29

  1. JP
    Jens Panse

    RWTH Aachen University, Germany

    1 publications · 33 citations

    1

    h-index

  2. FZ
    Fengkui Zhang

    Institute of Hematology & Blood Diseases Hospital, China

    1 publications · 38 citations

    1

    h-index

  3. RF
    Rong Fu

    Tianjin Medical University General Hospital, China

    1 publications · 38 citations

    1

    h-index

  4. JS
    Jeff Szer

    The Royal Melbourne Hospital, Australia

    1 publications · 33 citations

    1

    h-index

  5. JW
    Jianyu Weng

    Guangdong Academy of Medical Sciences, China

    1 publications · 38 citations

    1

    h-index

1–5 of 29

Institutions

26

  1. Apellis Pharmaceuticals (United States)

    Waltham, United States

    1 h-index

    1 publications

    33 citations

  2. Swedish Orphan Biovitrum (Sweden)

    Stockholm, Sweden

    1 h-index

    2 publications

    66 citations

  3. Guangdong Provincial People's Hospital

    Guangzhou, China

    1 h-index

    1 publications

    38 citations

  4. RWTH Aachen University

    Aachen, Germany

    1 h-index

    1 publications

    33 citations

  5. Roche (China)

    Shanghai, China

    1 h-index

    3 publications

    114 citations

  6. Kaiser Permanente South San Francisco Medical Center

    South San Francisco, United States

    1 h-index

    1 publications

    38 citations

  7. Duke University

    Durham, United States

    1 h-index

    1 publications

    33 citations

  8. Peking University People's Hospital

    Beijing, China

    1 h-index

    1 publications

    38 citations

1–8 of 26

Venues

  1. American Journal of Hematology

    AJH · 1 publications · 38 citations

    1

    h-index

  2. Critical Care Medicine

    1 publications · 79 citations

    1

    h-index

  3. Blood Advances

    1 publications · 33 citations

    1

    h-index

  4. Kidney International

    1 publications · 21 citations

1–4